Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
about
Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndromeBrief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.Influence of vaginal lactoferrin administration on amniotic fluid cytokines and its role against inflammatory complications of pregnancy.Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.
P2860
Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
@en
Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
@nl
type
label
Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
@en
Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
@nl
prefLabel
Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
@en
Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
@nl
P2093
P2860
P356
P1476
Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome
@en
P2093
Daniela Wojcik
Karol Charkiewicz
Monika Zbucka-Kretowska
Radoslaw Charkiewicz
P2860
P304
P356
10.1155/2014/835837
P577
2014-11-16T00:00:00Z